Igenomix at ASRM 2022
Thank you for joining Igenomix and Vitrolife at this year’s ASRM 2022 Scientific Congress & Expo in Anaheim, California. We hope you had the opportunity to learn more about our innovative new research and attend one of our LIVE studio sessions. If you were unable to join us, click on the button below for access to our studio sessions and more.
Click Here for Igenomix at ASRM
2022 PGT-A Webinar Series
View our PGT-A webinar series recordings. Click below to access the individual presentation recording links.
View Recordings
Endometrial microbiota is associated with reproductive outcome in infertile patient
New study led by Dr. Inmaculada Moreno shows that endometrial microbiota composition before embryo transfer is an useful biomarker to predict reproductive outcome, offering an opportunity to further improve diagnosis and treatments strategies
Learn more!
Vitrolife completes THE acquisition of Igenomix
Together, we create a global leader in reproductive health
It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.
Visit Vitrolife website